Assignee
UMECRINE AB
SE·3 granted patents·4 pending applications·1 citations·filing 2002–2022
Top patents by PatentIndex Score
7 records- 0170US8853190B2Steroids having increased water solubility and resistance against metabolism, and methods for their productionUMECRINE AB·Filed 2013·Granted Oct 7, 2014·1 cites·2 claims
- 0257US2024383941A13-alpha substituted 3-beta-hydroxy-17-oximated androstane compound for modulation of the alpha-3 subtype of the gabaa receptorUMECRINE AB·Filed 2022·Application pending·0 cites
- 0356US2013102579A1Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2012·Application pending·0 cites
- 0456US2013102578A1New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2012·Application pending·0 cites
- 0553US2015315231A1New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2015·Application pending·0 cites
- 0645US8372824B2GABA-steroid antagonists and their use for the treatment of CNS disordersUMECRINE AB·Filed 2012·Granted Feb 12, 2013·0 cites·6 claims
- 0745US7960367B2Pregnane steroids and their use in the treatment of CNS disordersUMECRINE AB·Filed 2002·Granted Jun 14, 2011·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when UMECRINE AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →